Shares of CPS Technologies Corporation (CPSH) have risen 19.5% since reporting second-quarter 2025 results, far outpacing the S&P 500’s 1.4% growth in the same period. Over the past month, CPSH has climbed 26.1%, again handily beating the broader market’s 2.6% growth. The sharp rally underscores investor enthusiasm around the company’s improving fundamentals and strong revenue growth trajectory.Revenue & EPS PerformanceFor the quarter ended June 28, 2025, CPSH reported revenues of $8.1 million, a record hig ...

Key Takeaways NVTS shares fell 18.3% in a month after weak Q2 results and outlook weighed on performance.Revenues slid 29.2% to $14.5M, with Q3 guidance impacted by tariffs and mobile business shift.NVTS sees AI data center and power transition as multi-quarter growth drivers for GaN and SiC.Navitas Semiconductor (NVTS) shares have dropped 18.3% in a month, underperforming the Zacks Computer and Technology sector’s return of 3%. The underperformance can be attributed to sluggish second-quarter 2025 results ...

SCOTTSDALE, Ariz., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Black Rock Coffee Bar, Inc. (“Black Rock Coffee Bar”) today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed initial public offering of its Class A common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The proposed offering is subject to market and other conditions, and there can be no assur ...

Key Takeaways Novo Nordisk gained FDA nod for Wegovy for treating MASH with liver fibrosis in adults.The ESSENCE trial showed Wegovy improved liver fibrosis and resolved steatohepatitis.Wegovy is the first GLP-1 therapy approved for MASH, a milestone in liver disease care.Novo Nordisk (NVO) announced that the FDA has granted accelerated approval to its blockbuster GLP-1 drug, Wegovy (semaglutide 2.4 mg) for a new indication.The regulatory body in the United States has now approved Wegovy for the treatment o ...

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. However, when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.While cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investo ...

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.While cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by it ...

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But for income investors, generating consistent cash flow from each of your liquid investments is your primary focus.While cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view i ...

SAN FRANCISCO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit styled Khan v. Lockheed Martin Corporation, et al., No. 1:25-cv-06197 (S.D.N.Y.) has been filed and seeks to represent investors who purchased or otherwise acquired Lockheed Martin Corporation (NYSE: LMT) securities between January 23, 2024 and July 21, 2025. The lawsuit comes in the wake of Lockheed’s Q2 2025 financial results, which resulted in the price of the company shares falling almost 11% on July 22, 2025. National sh ...

CHICAGO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, announced today its financial results for the second quarter and six-month period ended June 30, 2025. Financial Highlights for the Three and Six Months Ended June 30, 2025 Income StatementCosmos Health continued its positive trajectory in Q2 2025, delivering double-digit revenue growth of 11.66% and a 51.60% increase in gross profit. ...

Key Takeaways Occidental's vast Permian assets drive steady low-cost output and long-term growth potential.U.S. assets also fuel natural gas and NGL production, diversifying OXY's revenue streams.OXY's domestic footprint supports carbon capture projects, boosting sustainability efforts.Occidental Petroleum Corporation (OXY) holds one of the strongest domestic asset portfolios in the U.S. energy sector. Its significant presence in the Permian Basin, the most prolific oil-producing region in North America, pr ...